Malignant melanoma.
作者信息
Spitler L E
出版信息
J Invest Dermatol. 1976 Sep;67(3):435-41. doi: 10.1111/1523-1747.ep12514727.
PMID:787436
Abstract
Recent advances in our understanding of the pathology and prognosis of malignant melanoma make possible rationally designed immunotherapeutic studies. A number of immunologic studies suggest that there may be a specific immune response to melanoma-associated antigens in patients with melanoma; however, other studies have shown lack of specificity, so this issue remains to be definitively resolved. New immunotherapeutic agents, including BCG, TF, and levamisole, among others, offer the potential for improving therapy for patients.
摘要
相似文献
1
Malignant melanoma.
J Invest Dermatol. 1976 Sep;67(3):435-41. doi: 10.1111/1523-1747.ep12514727.
2
Immunotherapy for human malignant melanoma.人类恶性黑色素瘤的免疫疗法。
South Med J. 1975 Apr;68(4):495-503. doi: 10.1097/00007611-197504000-00025.
3
Immunotherapy of malignant melanoma.恶性黑色素瘤的免疫治疗
J Am Acad Dermatol. 1982 Apr;6(4 Pt 1):559-62. doi: 10.1016/s0190-9622(82)80382-4.
4
Immunology and cutaneous malignant melanoma.免疫学与皮肤恶性黑色素瘤
Int J Dermatol. 1976 Jan-Feb;15(1):1-18. doi: 10.1111/j.1365-4362.1976.tb05089.x.
5
Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current status.恶性黑色素瘤中的肿瘤定向免疫反应性与免疫治疗。现状。
Prog Exp Tumor Res. 1974;19:222-52. doi: 10.1159/000395859.
6
BCG immunotherapy of a mucous membrane malignant melanoma. Report of a case.卡介苗免疫疗法治疗黏膜恶性黑色素瘤。病例报告。
Oral Surg Oral Med Oral Pathol. 1976 Jul;42(1):73-9. doi: 10.1016/0030-4220(76)90032-3.
7
[Development in the immunotherapy of malignant melanoma].[恶性黑色素瘤免疫治疗的进展]
Hautarzt. 1976 Jan;27(1):1-7.
8
[Immunologic reactions in malignant melanoma of the skin in man].[人类皮肤恶性黑色素瘤中的免疫反应]
Vopr Onkol. 1975;21(4):74-80.
9
Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.人类恶性黑色素瘤的免疫学与免疫治疗：历史回顾与未来展望
Semin Oncol. 1975 Jun;2(2):155-74.
10
[Immunotherapy].[免疫疗法]
Acta Chir Belg. 1974 Mar;73(2):265-93.
Zotero 插件